• Mashup Score: 0
    Hawthorne Effect Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study - 1 year(s) ago

    October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interim recruitment results for the PREVUE-VALVE study, a clinical research study led by the Cardiovascular Research Foundation (CRF), that aims to quantify the prevalence of valvular heart disease (VHD). To date, Hawthorne Effect has successfully recruited over 1,000 patients in 48 states plus Hawaii. Patient recruitment also exceeded industry averages according to findings from the Association of Clinical Research Professionals for the below patient demographics, setting a new standard for inclusiveness: 15% African American compared to the industry standard of

    Source: www.dicardiology.com
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DAICeditor
      DAICeditor

      @DAICeditor @Hawthorne_ACTs @crfheart #HawthorneEffect announced interim recruitment results for the #PREVUE_VALVE study, a #clinicalresearch study led by #CRF, that aims to quantify the prevalence of valvular #heartdisease (#VHD): https://t.co/CNvGedFVqw

  • Mashup Score: 1
    Auditor And Risk Manager - EORTC - 1 year(s) ago

    Skip to content The Auditor and Risk manager works under the hierarchical supervision of the Chief Executive Officer. Main responsibilities / Major Activities Audit conducted by EORTC (internal, towards third parties) Manages all audits conducted by…

    Source: EORTC
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of EORTC
      EORTC

      📢 We are hiring! We are looking for an Auditor and Risk Manager to join our headquarters in #Brussels. Do you have experience in #ClinicalResearch and GCP #auditing? Apply now: https://t.co/S1gLyEBRoz #WorkWithUs #RiskManager #ClinicalTrials https://t.co/VmFDVLENUm

  • Mashup Score: 1
    Medable perspective: Key takeaways of recent FDA DCT draft guidance | Medable - 1 year(s) ago

    The recent release (May 2023) of the FDA’s Decentralized Clinical Trial (DCT) Draft Guidance has sparked a wave of excitement and anticipation within the field of clinical trials. This long-awaited guidance represents a significant milestone in the evolution of clinical trial methodologies, signaling clear support for the global shift towards expanded trial models. This guidance reinforces the…

    Source: www.medable.com
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of medableinc
      medableinc

      Medable's Pamela Tenaerts, CSO; Kevin Potgieter, VP Regulatory; & Mohammed Ali, CDO, provide their perspectives on the recent FDA draft guidance for DCTs. Read here: https://t.co/zFTGMDiHuF _______ #clinicaltrials #clinicalresearch #healthcare #decentralizedtrials

  • Mashup Score: 1
    Transforming Clinical Research - 1 year(s) ago

    This Viewpoint discusses specific areas of improvement in the National Institutes of Health’s funding of and research criteria for clinical trials to be inclusive, transparent, and broad reaching.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NHLBI_Translate
      NHLBI_Translate

      .@NIHDirector: In #JAMA viewpoint, @NIH leaders articulate principles for transforming #ClinicalResearch to meet health challenges. Center opportunities around people and #equity; prepare for #PublicHealth #emergencies; focus on #data and design; more... https://t.co/YgpvOX9GCh

  • Mashup Score: 0
    Kathryn Lawless first person to receive Lamzede in the US - 1 year(s) ago

    ISMRD is very excited for Kathryn Lawless, who is the first Alpha-Mannosidosis patient in the United States to receive Lamzede enzyme replacement therapy. Here, Kathryn’s mother Kyrsten talks about their experience with Lamzede infusions. Kathryn (age 5 will be 6 on May 30) has been receiving Enzyme Replacement Therapy (Lamzede) through infusion once a week for three weeks now. We decided to…

    Source: mailchi.mp
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of RabiHannaMD
      RabiHannaMD

      I am so proud of our team at ⁦@CleClinicKids⁩ ⁦@CleClinic_PHO⁩ who made this possible through #clinicalResearch and support from ⁦@sanofi⁩ #rareDiseases ⁦@ISMRD⁩ Kathryn Lawless first person to receive Lamzede in the US https://t.co/ZpohoTZq9K

  • Mashup Score: 0
    Cancer Stories: The Art of Oncology: At a Loss: Patient Deaths and Clinical Research Coordinators - 2 year(s) ago

    Listen to ASCO’s Journal of Clinical Oncology essay, by Dr. Hermioni Amonoo, a Carol Nadelson MD Distinguished Chair in Psychiatry at Brigham and Women’s Hospital and the Dana Farber Cancer Institute. The essay is followed by an interview with Amonoo and host Dr. Lidia Schapira. Amonoo puts out a call for support for clinical researcher coordinators to manage grief after patient death in…

    Source: aoopodcast.libsyn.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JCO_ASCO
      JCO_ASCO

      Check out #JCO Cancer Stories #podcast episode: 🎧 Listen to how clinical research coordinators cope with disenfranchised grief. ➡️ https://t.co/pOcMEkCQ0b #clinicalresearch #PallOnc @DanaFarber @DanaFarberNews @BrighamWomens @APSHQ @BWHPsyResidency https://t.co/sPNGjGY5ss

Load More